The aim of the COVend project is to deliver a new effective therapy against endothelial damage in ARDS for the clinical management of COVID-19 and other diseases.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

All posts reflect the views of COVend only

COVend

Org chart

Teams

Offices

COVend

Org chart

Teams

Offices

Related companies